IronBridge Private Wealth LLC lessened its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 69,238 shares of the exchange traded fund’s stock after selling 4,122 shares during the period. SPDR S&P Biotech ETF comprises 2.6% of IronBridge Private Wealth LLC’s portfolio, making the stock its 11th largest holding. IronBridge Private Wealth LLC owned about 0.09% of SPDR S&P Biotech ETF worth $6,841,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Tidemark LLC grew its position in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the last quarter. ORG Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at about $40,000. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at $40,000. ORG Wealth Partners LLC acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000. Finally, Howe & Rusling Inc. acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $49,000.
SPDR S&P Biotech ETF Price Performance
Shares of SPDR S&P Biotech ETF stock opened at $99.31 on Tuesday. The business has a 50-day moving average of $98.22 and a 200-day moving average of $96.64. The company has a market capitalization of $7.57 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $77.21 and a 1-year high of $105.47.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Best Stocks Under $5.00
- 3 S&P 500 Stocks With Sky High Risk-Adjusted Returns
- What is a Death Cross in Stocks?
- Trending Stocks: How to Spot, Trade, and Profit Safely
- What is Short Interest? How to Use It
- Roku’s Recovery Prospects: Why 2025 Could Be a Game-Changer
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.